SPOTLIGHT -
Pharm Exec 50: Growth from the Bottom Up
More consolidation didn't boost sales at the top, but a handful of nimble newcomers posted impressive growth on the other end of the curve.
Pharma's Next Top Model: Slimmer Business Models
The disease profiles pharma companies pursue should shape the business models that enable them to grow.